FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152038045> ?p ?o ?g. }

• W2152038045 endingPage "2866" @default.
• W2152038045 startingPage "2856" @default.
• W2152038045 abstract "Beta amyloid is one of the major histopathological hallmarks of Alzheimer's disease. We recently reported in vivo imaging of amyloid in 16 Alzheimer patients, using the PET ligand N-methyl[11C]2-(4'-methylaminophenyl)-6-hydroxy-benzothiazole (PIB). In the present study we rescanned these 16 Alzheimer patients after 2.0 +/- 0.5 years and have described the interval change in amyloid deposition and regional cerebral metabolic rate for glucose (rCMRGlc) at follow-up. Sixteen patients with Alzheimer's disease were re-examined by means of PET, using PIB and 2-[18F]fluoro-2-deoxy-d-glucose (FDG) after 2.0 +/- 0.5 years. The patients were all on cholinesterase inhibitor treatment and five also on treatment with the N-methyl-d-aspartate (NMDA) antagonist memantine. In order to estimate the accuracy of the PET PIB measurements, four additional Alzheimer patients underwent repeated examinations with PIB within 20 days (test-retest). Relative PIB retention in cortical regions differed by 3-7% in the test-retest study. No significant difference in PIB retention was observed between baseline and follow-up while a significant (P < 0.01) 20% decrease in rCMRGlc was observed in cortical brain regions. A significant negative correlation between rCMRGlc and PIB retention was observed in the parietal cortex in the Alzheimer patients at follow-up (r = 0.67, P = 0.009). A non-significant decline in Mini-Mental State Examination (MMSE) score from 24.3 +/- 3.7 (mean +/- standard deviation) to 22.7 +/- 6.1 was measured at follow-up. Five of the Alzheimer patients showed a significant decline in MMSE score of >3 (21.4 +/- 3.5 to 15.6 +/- 3.9, P < 0.01) (AD-progressive) while the rest of the patients were cognitively more stable (MMSE score = 25.6 +/- 3.1 to 25.9 +/- 3.7) (AD-stable) compared with baseline. A positive correlation (P = 0.001) was observed in the parietal cortex between Rey Auditory Verbal Learning (RAVL) test score and rCMRGlc at follow-up while a negative correlation (P = 0.018) was observed between RAVL test and PIB retention in the parietal at follow-up. Relatively stable PIB retention after 2 years of follow-up in patients with mild Alzheimer's disease suggests that amyloid deposition in the brain reaches a plateau by the early clinical stages of Alzheimer's disease and therefore may precede a decline in rCMRGlc and cognition. It appears that anti-amyloid therapies will need to induce a significant decrease in amyloid load in order for PIB PET images to detect a drug effect in Alzheimer patients. FDG imaging may be able to detect a stabilization of cerebral metabolism caused by therapy administered to patients with a clinical diagnosis of Alzheimer's disease." @default.
• W2152038045 created "2016-06-24" @default.
• W2152038045 creator A5027478853 @default.
• W2152038045 creator A5028226944 @default.
• W2152038045 creator A5034876947 @default.
• W2152038045 creator A5045080903 @default.
• W2152038045 creator A5050853855 @default.
• W2152038045 creator A5055059044 @default.
• W2152038045 creator A5072392176 @default.
• W2152038045 creator A5075774660 @default.
• W2152038045 creator A5087294774 @default.
• W2152038045 creator A5089411086 @default.
• W2152038045 date "2006-09-29" @default.
• W2152038045 modified "2023-10-11" @default.
• W2152038045 title "Two-year follow-up of amyloid deposition in patients with Alzheimer's disease" @default.
• W2152038045 cites W106087326 @default.
• W2152038045 cites W1835478781 @default.
• W2152038045 cites W1837941181 @default.
• W2152038045 cites W1847168837 @default.
• W2152038045 cites W1919969592 @default.
• W2152038045 cites W1964006251 @default.
• W2152038045 cites W1972816877 @default.
• W2152038045 cites W1985603549 @default.
• W2152038045 cites W2002996527 @default.
• W2152038045 cites W2013207729 @default.
• W2152038045 cites W2015629233 @default.
• W2152038045 cites W2024921053 @default.
• W2152038045 cites W2024940817 @default.
• W2152038045 cites W2033917523 @default.
• W2152038045 cites W2035235911 @default.
• W2152038045 cites W2037545190 @default.
• W2152038045 cites W2046638602 @default.
• W2152038045 cites W2049072059 @default.
• W2152038045 cites W2052742260 @default.
• W2152038045 cites W2054089714 @default.
• W2152038045 cites W2054600348 @default.
• W2152038045 cites W2059875787 @default.
• W2152038045 cites W2066977853 @default.
• W2152038045 cites W2084077702 @default.
• W2152038045 cites W2089613882 @default.
• W2152038045 cites W2092078486 @default.
• W2152038045 cites W2093470651 @default.
• W2152038045 cites W2103440561 @default.
• W2152038045 cites W2115077024 @default.
• W2152038045 cites W2116488337 @default.
• W2152038045 cites W2123021161 @default.
• W2152038045 cites W2135259587 @default.
• W2152038045 cites W2159789463 @default.
• W2152038045 cites W2167720733 @default.
• W2152038045 doi "https://doi.org/10.1093/brain/awl178" @default.
• W2152038045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16854944" @default.
• W2152038045 hasPublicationYear "2006" @default.
• W2152038045 type Work @default.
• W2152038045 sameAs 2152038045 @default.
• W2152038045 citedByCount "574" @default.
• W2152038045 countsByYear W21520380452012 @default.
• W2152038045 countsByYear W21520380452013 @default.
• W2152038045 countsByYear W21520380452014 @default.
• W2152038045 countsByYear W21520380452015 @default.
• W2152038045 countsByYear W21520380452016 @default.
• W2152038045 countsByYear W21520380452017 @default.
• W2152038045 countsByYear W21520380452018 @default.
• W2152038045 countsByYear W21520380452019 @default.
• W2152038045 countsByYear W21520380452020 @default.
• W2152038045 countsByYear W21520380452021 @default.
• W2152038045 countsByYear W21520380452022 @default.
• W2152038045 countsByYear W21520380452023 @default.
• W2152038045 crossrefType "journal-article" @default.
• W2152038045 hasAuthorship W2152038045A5027478853 @default.
• W2152038045 hasAuthorship W2152038045A5028226944 @default.
• W2152038045 hasAuthorship W2152038045A5034876947 @default.
• W2152038045 hasAuthorship W2152038045A5045080903 @default.
• W2152038045 hasAuthorship W2152038045A5050853855 @default.
• W2152038045 hasAuthorship W2152038045A5055059044 @default.
• W2152038045 hasAuthorship W2152038045A5072392176 @default.
• W2152038045 hasAuthorship W2152038045A5075774660 @default.
• W2152038045 hasAuthorship W2152038045A5087294774 @default.
• W2152038045 hasAuthorship W2152038045A5089411086 @default.
• W2152038045 hasConcept C126322002 @default.
• W2152038045 hasConcept C134018914 @default.
• W2152038045 hasConcept C142724271 @default.
• W2152038045 hasConcept C15744967 @default.
• W2152038045 hasConcept C164705383 @default.
• W2152038045 hasConcept C2775842073 @default.
• W2152038045 hasConcept C2779134260 @default.
• W2152038045 hasConcept C2779483572 @default.
• W2152038045 hasConcept C2779484449 @default.
• W2152038045 hasConcept C2781073650 @default.
• W2152038045 hasConcept C2989005 @default.
• W2152038045 hasConcept C502032728 @default.
• W2152038045 hasConcept C71924100 @default.
• W2152038045 hasConcept C90924648 @default.
• W2152038045 hasConceptScore W2152038045C126322002 @default.
• W2152038045 hasConceptScore W2152038045C134018914 @default.
• W2152038045 hasConceptScore W2152038045C142724271 @default.
• W2152038045 hasConceptScore W2152038045C15744967 @default.
• W2152038045 hasConceptScore W2152038045C164705383 @default.
• W2152038045 hasConceptScore W2152038045C2775842073 @default.

• next